摘要
目的:探讨了食管癌患者手术前后血清E-cad、SICAM-1和IL-8水平的变化及临床意义。方法:应用放射免疫分析和酶联法对33例食管癌患者进行了手术前后血清E-cad、SICAM-1和IL-8检测,并与35名正常健康人作比较。结果:食管癌患者在手术前血清E-cad、SICAM-1和IL-8水平均非常显著地高于正常人组(P<0.01),手术治疗6个月后则与正常人组比较无显著性差异(P>0.05)。血清E-cad水平与SICAM-1、IL-8水平呈正相关(r=0.6188、0.5012,P<0.01)。结论:检测食管癌患者手术前后E-cad、SICAM-1和IL-8水平的变化具有真实的价值。
Objective To explore the clinical significance of determining the changes on serum E-cad,SICAM-1 and IL-8 levels after operation in patients with esophageal cancer.Methods Serum IL-8(with RIA) and serum E-cad,ICAM-1(with ELISA) levels were determined in 33 patients with esophageal cancer both before and after operation as well as in 35 normal healthy controls.Results Before operation the serum E-cad,ICAM-1 and IL-8 levels in the patients were significantly higher than those in the controls(P 0.01).After operation for 6 months serum E-cad,ICAM-1and IL-8 levels showed no more difference from the controls(P 0.05).Serum E-cad level was positively correlated with ICAM-1,IL-8 levels(r = 0.6188,0.5012,P 0.01).Conclusion Changes of serum E-cad ICAM-1and IL-8 levels might be of substantial prognostic value in patients with esophageal cancer.
出处
《放射免疫学杂志》
CAS
2013年第4期395-396,共2页
Journal of Radioimmanology
关键词
食管癌
上皮钙粘蛋白
可溶性细胞粘附分子-1
白细胞介素-8
esophageal cancer
E-cadherin(E-cad)
soluble intercellular adhesion molecnle-1(SICAM-1)
interleukin-8(IL8)